Cellebrite DI (CLBT) Change in Accured Expenses (2020 - 2026)

Cellebrite DI has reported Change in Accured Expenses for 7 years, with the latest figure at $6.9 million in Q2 2026.

• On a quarterly basis, Change in Accured Expenses fell 60.86% year-over-year to $6.9 million in Q2 2026; TTM through Jun 2026 was -$4.7 million, a 117.88% decrease from a year earlier, with the FY2025 full-year figure at $4.2 million, down 75.84% from the prior year.
• Change in Accured Expenses was $6.9 million for Q2 2026 at Cellebrite DI, up from -$10.4 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $17.6 million in Q2 2025, with the low at -$12.2 million in Q1 2025.
• Average Change in Accured Expenses over 5 years is $567777.8, with a median of $2.1 million recorded in 2022.
• The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses soared 809.28% in 2024, then sank 187.46% in 2025.
• Over 5 years, Change in Accured Expenses stood at -$2.1 million in 2022, then soared by 370.44% to $5.6 million in 2023, then soared by 110.41% to $11.7 million in 2024, then sank by 41.9% to $6.8 million in 2025, then rose by 1.29% to $6.9 million in 2026.
• The last three Change in Accured Expenses figures came in at $6.9 million (Q2 2026), -$10.4 million (Q1 2026), and $6.8 million (Q4 2025), per Business Quant data.